Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes - Concepedia

Concepedia

Publication | Open Access

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

DOI Full Paper Access

170

Citations

34

References

2005

Year

B Charbonnel, Guntram Schernthaner, P. Brunetti, David R. Matthews, Richard Urquhart, Meng H. Tan, M Hanefeld

Diabetes ManagementLong-term EfficacyDiabetesPharmacologyType 2PharmacotherapyDiabetes MellitusAdd-on Pioglitazone TherapyMedicine

References

	Year	Citations

Page 1